Shilpa Pharma: A Leading Oncology API Manufacturer in India
Posted by zany
from the Business category at
09 Oct 2025 08:45:34 am.
Share this page: 
? Shilpa Pharma: Excellence in Oncology API Manufacturing
Established in 1987, Shilpa Pharma, under Shilpa Medicare Ltd., has been at the forefront of oncology API production. With state-of-the-art facilities in Raichur, Karnataka, and a commitment to global quality standards, Shilpa Pharma caters to the increasing global demand for cancer treatments.
? Comprehensive CDMO Services
Shilpa Pharma offers a full spectrum of CDMO services in India, including:
- Route Scouting & Process Development: Innovative strategies for efficient synthesis.
- Scale-Up & Commercial Manufacturing: From laboratory to large-scale production.
- Regulatory Support: Assistance with filings and compliance.
- Analytical Services: Ensuring product quality and consistency.
These services are complemented by a robust infrastructure that meets international regulatory standards, including approvals from the US FDA.
? Global Reach and Client Testimonials
Shilpa Pharma's commitment to quality and reliability has garnered trust from global clients, including biotech firms in the United States and Europe. Their expertise in oncology API manufacturing has been instrumental in advancing clinical trials and ensuring timely delivery of critical materials.
? Recognized Among Leading API Manufacturers in India
Shilpa Pharma's dedication to excellence places it among the top oncology API manufacturers in India. Its comprehensive CDMO services, coupled with a focus on innovation and quality, make it a preferred partner for pharmaceutical companies worldwide.
Conclusion
As the demand for oncology treatments continues to rise, Shilpa Pharma remains a pivotal player in the global pharmaceutical landscape. Through its specialized CDMO services and commitment to quality, Shilpa Pharma is well-positioned to meet the evolving needs of the oncology sector.
0 Comments